Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy (Q44043887)

29 November 2017

title

Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy (English)

1 reference

29 November 2017

D A Jabs

1

1 reference

29 November 2017

S G Bolton

series ordinal

2

1 reference

29 November 2017

J P Dunn

series ordinal

3

1 reference

29 November 2017

A G Palestine

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

American Journal of Ophthalmology

29 November 2017

published in

1 reference

29 November 2017

volume

126

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

817-822

1 reference

Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

AIDS and ophthalmology: a period of transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Cli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Antiretroviral therapy for HIV infection: promises and problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

Ganciclovir implant exchange. Timing, surgical procedure, and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900285-2

10.1016/S0002-9394(98)00285-2

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference